Lindbrook Capital, LLC Integra Lifesciences Holdings Corp Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Lindbrook Capital, LLC holds 274 shares of IART stock, worth $6,617. This represents 0.0% of its overall portfolio holdings.

Number of Shares

274

Previous 912 69.96%

Holding current value

$6,617

Previous $26,000 84.62%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$17.14 - $31.74 $10,935 - $20,250	-638 Reduced 69.96%	274 $4,000
Q2 2024 Jul 31, 2024	BUY	$23.14 - $34.72 $19,946 - $29,928	862 Added 1724.0%	912 $26,000
Q1 2024 Apr 25, 2024	SELL	$33.4 - $45.2 $233 - $316	-7 Reduced 12.28%	50 $1,000
Q4 2023 Jan 31, 2024	SELL	$34.21 - $44.59 $6,842 - $8,918	-200 Reduced 77.82%	57 $2,000
Q3 2023 Oct 25, 2023	BUY	$37.8 - $45.97 $5,103 - $6,205	135 Added 110.66%	257 $9,000
Q2 2023 Jul 28, 2023	SELL	$37.95 - $58.98 $5,996 - $9,318	-158 Reduced 56.43%	122 $5,000
Q1 2023 Apr 26, 2023	BUY	$52.61 - $60.49 $631 - $725	12 Added 4.48%	280 $16,000
Q4 2022 Jan 24, 2023	BUY	$42.17 - $58.6 $3,626 - $5,039	86 Added 47.25%	268 $0
Q3 2022 Nov 10, 2022	BUY	$42.28 - $57.17 $549 - $743	13 Added 7.69%	182 $8,000
Q2 2022 Aug 01, 2022	BUY	$53.86 - $66.52 $53 - $66	1 Added 0.6%	169 $9,000
Q1 2022 Apr 21, 2022	BUY	$62.86 - $69.24 $817 - $900	13 Added 8.39%	168 $11,000
Q1 2020 Apr 22, 2020	BUY	$36.67 - $61.04 $4,363 - $7,263	119 Added 330.56%	155 $7,000
Q4 2018 Feb 07, 2019	BUY	$42.62 - $64.51 $1,534 - $2,322	36 New	36 $1,000

Others Institutions Holding IART

# of Institutions

241

Shares Held

75.3M

Call Options Held

585K

Put Options Held

21.3K

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $2.02B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Integra Lifesciences Holdings Corp Transaction History